For: | Benedicto A, García-Kamiruaga I, Arteta B. Neuropilin-1: A feasible link between liver pathologies and COVID-19. World J Gastroenterol 2021; 27(24): 3516-3529 [PMID: 34239266 DOI: 10.3748/wjg.v27.i24.3516] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3516.htm |
Number | Citing Articles |
1 |
Carlotta Hoffmann, Philipp A. Gerber, Claudia Cavelti-Weder, Louisa Licht, Reham Kotb, Rania Al Dweik, Michele Cherfane, Stefan R. Bornstein, Nikolaos Perakakis. Liver, NAFLD and COVID-19. Hormone and Metabolic Research 2022; 54(08): 522 doi: 10.1055/a-1834-9008
|
2 |
Ali Norouzi, Mahsa Liaghat, Maryam Bakhtiyari, Seyed Mostafa Noorbakhsh Varnosfaderani, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Tahereh Molania. The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC). Oral Oncology 2023; 144: 106483 doi: 10.1016/j.oraloncology.2023.106483
|
3 |
Kiarash Saleki, Parsa Alijanizadeh, Abbas Azadmehr. Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?. Biomedicine & Pharmacotherapy 2023; 167: 115558 doi: 10.1016/j.biopha.2023.115558
|
4 |
Jinqiu Zhao, Jie Bai, Fengling Peng, Chan Qiu, Yongguo Li, Li Zhong. USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. Cell Death & Disease 2023; 14(1) doi: 10.1038/s41419-022-05527-9
|
5 |
Kenneth Lundstrom, Altijana Hromić-Jahjefendić, Esma Bilajac, Alaa A.A. Aljabali, Katarina Baralić, Nagwa A. Sabri, Eslam M. Shehata, Mohamed Raslan, Ana Cláudia B.H. Ferreira, Lidiane Orlandi, Ángel Serrano-Aroca, Murtaza M. Tambuwala, Vladimir N. Uversky, Vasco Azevedo, Khalid J. Alzahrani, Khalaf F. Alsharif, Ibrahim F. Halawani, Fuad M. Alzahrani, Elrashdy M. Redwan, Debmalya Barh. COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity. Cellular Signalling 2023; 101: 110495 doi: 10.1016/j.cellsig.2022.110495
|
6 |
Liudmila V. Spirina, Vladimir N. Masunov, Denis A. Dyakov, Olga E. Akbasheva, Amina Y. Kebekbayeva, Igor Yu. Shuvalov, Nadezhda V. Masunova, Irina V. Kovaleva, Yumzhana Dagbaeva. Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions. Indian Journal of Clinical Biochemistry 2023; 38(4): 437 doi: 10.1007/s12291-022-01089-x
|
7 |
Philipp Hohlstein, Eileen Schumacher, Samira Abu Jhaisha, Jule K. Adams, Maike R. Pollmanns, Carolin V. Schneider, Karim Hamesch, Katarina Horvathova, Theresa H. Wirtz, Frank Tacke, Christian Trautwein, Ralf Weiskirchen, Alexander Koch. Soluble Neuropilin-1 Is Elevated in Sepsis and Correlates with Organ Dysfunction and Long-Term Mortality in Critical Illness. International Journal of Molecular Sciences 2024; 25(10): 5438 doi: 10.3390/ijms25105438
|
8 |
Changfa Fan, Yong Wu, Xiong Rui, Yuansong Yang, Chen Ling, Susu Liu, Shunan Liu, Youchun Wang. Animal models for COVID-19: advances, gaps and perspectives. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01087-8
|
9 |
Jiayan Tang, Zaiyong Yang, Huotang Qin, Yu Huang, Minqing Li, Qing Deng, Ling Li, Xiaolong Li. Exploring potential therapeutic strategy for hepatocellular carcinoma and COVID-19 using bioinformatics analysis. Egyptian Journal of Medical Human Genetics 2024; 25(1) doi: 10.1186/s43042-024-00560-z
|
10 |
Maria Guarino, Valentina Cossiga, Mario Capasso, Chiara Mazzarelli, Filippo Pelizzaro, Rodolfo Sacco, Francesco Paolo Russo, Alessandro Vitale, Franco Trevisani, Giuseppe Cabibbo. Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma. Journal of Clinical Medicine 2022; 11(15): 4475 doi: 10.3390/jcm11154475
|
11 |
Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, Zili Zhang, Shizhong Zheng. COVID‐19‐associated liver injury: Adding fuel to the flame. Cell Biochemistry and Function 2023; 41(8): 1076 doi: 10.1002/cbf.3883
|
12 |
Chin-Wen Hsu, Wan-Wen Yang, Chia-Yi Hou, I-Jung Feng, Ting-Yi Huang, Pei-Lun Lee, How-Ran Guo, Chien-Yuan Huang, Shih-Bin Su. Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate. Life 2023; 13(12): 2326 doi: 10.3390/life13122326
|
13 |
Luhong Wang, Yinan Ding, Chuanyong Zhang, Rong Chen, Afsheen Raza. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients. PLOS ONE 2022; 17(5): e0269249 doi: 10.1371/journal.pone.0269249
|
14 |
O. A. Gomazkov. Neuropilin Is a New Player in the Pathogenesis of COVID-19. Neurochemical Journal 2022; 16(2): 130 doi: 10.1134/S1819712422020064
|
15 |
Yuanhui Guo, Baixuan Shen, Chaoxuan Lou, Li Wang, Ying Li. IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01483-2
|
16 |
Maria Mercado-Gómez, Endika Prieto-Fernández, Naroa Goikoetxea-Usandizaga, Laura Vila-Vecilla, Mikel Azkargorta, Miren Bravo, Marina Serrano-Maciá, Leire Egia-Mendikute, Rubén Rodríguez-Agudo, Sofia Lachiondo-Ortega, So Young Lee, Alvaro Eguileor Giné, Clàudia Gil-Pitarch, Irene González-Recio, Jorge Simón, Petar Petrov, Ramiro Jover, Luis Alfonso Martínez-Cruz, June Ereño-Orbea, Teresa Cardoso Delgado, Felix Elortza, Jesús Jiménez-Barbero, Ruben Nogueiras, Vincent Prevot, Asis Palazon, María L. Martínez-Chantar. The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-03789-9
|
17 |
Fares E M Ali, Mostafa K Abd El-Aziz, Mahmoud M Ali, Osama M Ghogar, Adel G Bakr. COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells. World Journal of Gastroenterology 2023; 29(3): 425-449 doi: 10.3748/wjg.v29.i3.425
|
18 |
Julian Mustroph, Julian Hupf, Maria J. Baier, Katja Evert, Christoph Brochhausen, Katharina Broeker, Christine Meindl, Benedikt Seither, Carsten Jungbauer, Matthias Evert, Lars S. Maier, Stefan Wagner. Cardiac Fibrosis Is a Risk Factor for Severe COVID-19. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.740260
|